Depth filters are highly effective at removing impurities due to their design and composition. However, the materials added for enhanced filtration may introduce risks to the drug product. As a result, material safety remains a major concern for both pharmaceutical manufacturers and regulators when depth filters are employed.
Evaluation is typically recommended from the following aspects:
Extractables and Leachables
In both biopharmaceutical and traditional pharmaceutical filtration processes, it is critical to ensure that the filter itself does not introduce extractables or leachables that could compromise the safety or efficacy of the final product.
Extractables are substances released from the filter into a test solution under specific extraction conditions, such as elevated reflux temperature and extended exposure time. Leachables are generally a subset of extractables that may migrate into the drug product under normal process conditions.
Potential sources of leachables include surfactants, wetting agents, process additives from the filter assembly, process-generated debris, cellulose, filter aids, as well as filter housings and gaskets.
Extractables and leachables studies are typically conducted by manufacturers. If the filter is used beyond its recommended limits, focused evaluation is necessary. The closer a filter is used toward the end of the pharmaceutical manufacturing process, the more critical the assessment of extractables and leachables becomes. This may indicate potential incompatibility between the filter and the drug product, as well as a significant impact on filter performance. Filter qualification assessments must additionally account for the types and amounts of extractables.
Conductivity
Conductivity is commonly used to assess flushing efficiency and can be easily monitored either online or offline.
It is a fast and cost-effective method that provides a non-specific combined value of all ionic species.
Total Organic Carbon (TOC)
TOC is a widely used method for assessing filter flush as well as hardware CIP processes. In depth filters, TOC mainly originates from cellulose and resin binders. TOC monitoring helps detect organic compounds and carbon-based extractables to prevent them from entering the process stream.
Filters should be flushed according to the manufacturer’s recommendations.
Toxicity / Biocompatibility Testing
Filters should not contain toxic substances or any materials that could compromise product quality if released into the process stream. Toxicity testing data are typically available from the manufacturer to support validation studies.
Endotoxins and (1,3)-β-D-Glucans
Due to their composition and application, depth filters may pose a risk of biologically active contaminations. Two potential contaminants are bacterial endotoxins and (1,3)-β-D-glucans, both of which can trigger immune responses and be detected by the Limulus Amebocyte Lysate (LAL) assay. The levels of these contaminants must be monitored and controlled.
Particle shedding
Particle shedding refers to the release of particulate matter from the filter into the process stream. Potential sources of particles during filtration include cellulose and inorganic filter aids. Pre-flushing the filter before use can effectively reduce particle or cellulose shedding. It is generally recommended to perform pre-flushing of depth filters according to the manufacturer’s validation guidelines.